Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kriegmair

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Chemistry and Laboratory Medicine|March 15, 2003
Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?Brigitte Mahnert, Stephan Tauber, Martin Kriegmair, et al.
Urologia Internationalis|September 1, 2024
Prediction of Clinically Significant Prostate Cancer Using Multiparametric MRI, Biparametric MRI, and Clinical ParametersMaximilian Oberneder, Thomas Henzler, Martin Kriegmair, et al.
The Journal of Urology|July 20, 2002
Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopyMartin Kriegmair, Dirk Zaak, Karl-Heinz Rothenberger, et al.
Urology|February 27, 2007
Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladderEdwin Hungerhuber, Herbert Stepp, Martin Kriegmair, et al.
The Journal of Urology|May 16, 2012
Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopyH Barton Grossman, Arnulf Stenzl, Yves Fradet, et al.
Cancer|September 7, 2002
Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesionsDirk Zaak, Edwin Hungerhuber, Peter Schneede, et al.
The Journal of Urology|September 21, 2010
Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancerArnulf Stenzl, Maximilian Burger, Yves Fradet, et al.
Urologic Oncology|March 24, 2012
Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL)M J Bader, Herbert Stepp, Wolfgang Beyer, et al.
Scientific Reports|June 3, 2021
Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumorsNairveen Ali, Christian Bolenz, Tilman Todenhöfer, et al.
Urologia Internationalis|April 16, 2004
Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX - in vivo experiments on the dunning rat tumor modelDirk Zaak, Ronald Sroka, Susanne Stocker, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Chemistry and Laboratory Medicine|March 15, 2003
Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?Brigitte Mahnert, Stephan Tauber, Martin Kriegmair, et al.
Urologia Internationalis|September 1, 2024
Prediction of Clinically Significant Prostate Cancer Using Multiparametric MRI, Biparametric MRI, and Clinical ParametersMaximilian Oberneder, Thomas Henzler, Martin Kriegmair, et al.
The Journal of Urology|July 20, 2002
Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopyMartin Kriegmair, Dirk Zaak, Karl-Heinz Rothenberger, et al.
Urology|February 27, 2007
Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladderEdwin Hungerhuber, Herbert Stepp, Martin Kriegmair, et al.
The Journal of Urology|May 16, 2012
Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopyH Barton Grossman, Arnulf Stenzl, Yves Fradet, et al.
Cancer|September 7, 2002
Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesionsDirk Zaak, Edwin Hungerhuber, Peter Schneede, et al.
The Journal of Urology|September 21, 2010
Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancerArnulf Stenzl, Maximilian Burger, Yves Fradet, et al.
Urologic Oncology|March 24, 2012
Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL)M J Bader, Herbert Stepp, Wolfgang Beyer, et al.
Scientific Reports|June 3, 2021
Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumorsNairveen Ali, Christian Bolenz, Tilman Todenhöfer, et al.
Urologia Internationalis|April 16, 2004
Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX - in vivo experiments on the dunning rat tumor modelDirk Zaak, Ronald Sroka, Susanne Stocker, et al.
Pageof 2